Intas Pharmaceuticals

Intas Pharmaceuticals, Ltd. is a prominent global player in the pharmaceutical industry, specialising in the development, manufacturing, and marketing of generics, biosimilars, and added value medicines. Established in 1976, the company has experienced rapid growth, achieving USD 2.4 billion in sales for the year 2023-24 and operating in over 85 countries. Approximately 70% of its revenue is derived from international markets, particularly in the EU and US. With a workforce of 19,000 employees, Intas has a strong focus on research and development, dedicating more than 550 personnel to this critical area.

Services include:
- Biologics
- Finished Dosage Forms
- Active Pharmaceutical Ingredients (APIs)
- Plasma-Derived Therapeutics
- Formulation Development
- Regulatory Services

Intas Pharmaceuticals is committed to delivering high-quality pharmaceuticals while focusing on innovation, customer satisfaction, and societal care. For more information, please visit intaspharma.com.